NIDA Quick Screen V1.0 1
The NIDA-modified ASSIST was adapted from the World Health Organization (WHO) Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), Version 3.0, developed and published by WHO (available at
Download NIDA Quick Screen V1.0 1
Information
Domain:
Source:
Link to this page:
Documents from same domain
Understanding Drug Abuse and Addiction
nida.nih.govdisruptive effects. Research shows that combining addiction treatment medications with behavioral therapy is the best way to ensure success for most patients. Treatment ... influences the reward circuit and the ability to learn. When the optimal concentration of glutamate is altered by drug abuse, the
Alcohol Use Disorders Identification Test (AUDIT)
nida.nih.govscreening tool developed by the World Health Organization (WHO) to assess alcohol consumption, drinking behaviors, and alcohol-related problems. Both a clinician-administered version (page 1) and a self-report version of the AUDIT (page 2) are provided. Patients should be encouraged to answer the AUDIT questions in terms of standard drinks. A chart
Neurotransmission Fact Sheet
nida.nih.govCorpus callosum connects the two hemispheres Hemispheres of the cerebral cortex: Lobes of the cerebral cortex: Module 1 Located below the crown of the head Processes sensory information from the whole body (information about pain, touch, and pressure) Located behind the temples and just above the ears In charge of making sense of the
Sample Patient Agreement Forms - nida.nih.gov
nida.nih.govPatient Agreement Form. Patient Name: Medical Record Number: Addressograph Stamp: AGREEMENT FOR LONG TERM CONTROLLED SUBSTANCE PRESCRIPTIONS The use of (print names . of medication(s)) may cause addiction and is only one part of the treatment . for: (print name of condition—e.g., pain, anxiety, etc.). The goals of this medicine are:
Commonly Abused Drugs Chart
nida.nih.govencourage and support HIV screening and inform patients that highly active antiretroviral therapy (HAART) has proven effective in combating HIV, including among drug-abusing Prescription Medications This chart may be reprinted. Citation of the source is appreciated.
Clinical Opiate Withdrawl Scale
nida.nih.govClinical Opiate Withdrawal Scale Introduction The Clinical Opiate Withdrawal Scale (COWS) is an 11-item scale designed to be administered by a clinician. This tool can be used in both inpatient and outpatient settings to reproducibly rate common signs and symptoms of opiate withdrawal and monitor these symptoms over time. The summed
Drugs, Brains, and Behavior The Science of Addiction
nida.nih.govdrug abuse takes on individuals, families, and communities. Despite these advances, many people today do not understand why people become addicted to drugs or how drugs change the brain to foster compulsive drug use. This booklet aims to fill that knowledge gap by providing scientific information about the disease of drug
Preventing Drug Use Among Children and Adolescents …
nida.nih.govincluding the underage use of legal drugs (e.g., tobacco or alcohol); the use of illegal drugs (e.g., marijuana or heroin); and the inappropriate use of legally obtained substances (e.g., inhalants), prescription medications, or over-the-counter drugs (Johnston et al. 2002). Prevention programs should address the type of drug abuse problem in the
Instituto Nacional sobre el Abuso de Drogas Cómo Prevenir ...
nida.nih.govInstituto Nacional sobre el Abuso de Drogas 3 tales como la edad, el sexo, y la cultura, para mejorar la eficacia del programa.21 Planificación de la Prevención Programas para la familia Los programas de prevención para las familias deben
National Institute on Drug Abuse Principles of Drug Abuse ...
nida.nih.govTreatment for Criminal Justice Populations | A Research-Based Guide National Institute on Drug Abuse. 3. 1 1. Drug addiction is a brain disease that affects behavior. Drug addiction has well-recognized cognitive, behavioral, and physiological characteristics that contribute to …
Related documents
A. WHO - ASSIST V3
www.who.intA. WHO - ASSIST V3.0 INTERVIEWER ID ID CCOUNTRY CCLINIC PATIENT IDID DDATE INTRODUCTION ((Please read to patient Please read to patient Please read to patient )) Thank you for agreeing to take part in this brief interview about alcohol, tobacco products and other drugs. I am going to ask you some questions about your experience of using these substances …